Latest filing published 11 Jan 2023 for Imago BioSciences, Inc., €8.3M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Laura G. Eichorn is a declared insider of Imago BioSciences, Inc., with filings sourced from SEC (Form 4). In total, 12 filings cover trades dated from 12 January 2022 to 11 January 2023.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 11 January 2023, reports a transaction of €8.3M in Imago BioSciences, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations